We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

82 hedge funds and large institutions have $367M invested in Minerva Neurosciences in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

119% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 16

54% more capital invested

Capital invested by funds: $238M → $367M (+$129M)

12% more funds holding

Funds holding: 73 → 82 (+9)

0.12% more ownership

Funds ownership: 9.3% → 9.42% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
82
Holders Change
+9
Holders Change %
+12.33%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
35
Reduced
16
Closed
4
Calls
$335K
Puts
–
Net Calls
+$335K
Net Calls Change
+$221K

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$11.1M
2
BlackRock
BlackRock
New York
+$2.5M
3
Millennium Management
Millennium Management
New York
+$2.46M
4
MWNA
Marshall Wace North America
New York
+$1.3M
5
NLVP
New Leaf Venture Partners
New York
+$1.22M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.5M
2
HCMT
Highland Capital Management (Texas)
Texas
-$3.67M
3
JG
Jefferies Group
New York
-$1.89M
4
DCM
DAFNA Capital Management
California
-$977K
5
Franklin Resources
Franklin Resources
California
-$938K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$1.53M +$1.15M +15,247 New
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$1.51M +$1.13M +15,036 New
JG
28
Jefferies Group
New York
$1.49M -$1.89M -25,202 -63%
Goldman Sachs
29
Goldman Sachs
New York
$1.3M +$531K +7,066 +121%
BCM
30
Bridgeway Capital Management
Texas
$1.2M -$470K -6,250 -34%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$1.14M +$373K +4,963 +78%
Citadel Advisors
32
Citadel Advisors
Florida
$1.01M +$758K +10,085 New
Deutsche Bank
33
Deutsche Bank
Germany
$942K +$40.1K +533 +6%
OAM
34
Oxford Asset Management
United Kingdom
$933K +$699K +9,303 New
AA
35
ALPS Advisors
Colorado
$861K +$116K +1,547 +22%
GCP
36
GSA Capital Partners
United Kingdom
$831K +$622K +8,275 New
Charles Schwab
37
Charles Schwab
California
$823K – – –
AWCI
38
Alpine Woods Capital Investors
New York
$770K +$106K +1,416 +23%
Squarepoint
39
Squarepoint
New York
$759K +$223K +2,967 +65%
TA
40
Teachers Advisors
New York
$755K +$1.13K +15 +0.2%
Morgan Stanley
41
Morgan Stanley
New York
$752K -$69.3K -922 -11%
Swiss National Bank
42
Swiss National Bank
Switzerland
$720K – – –
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$714K +$535K +7,117 New
TD Asset Management
44
TD Asset Management
Ontario, Canada
$629K +$2.86K +38 +0.6%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$592K +$2.93K +39 +0.7%
AllianceBernstein
46
AllianceBernstein
Tennessee
$579K – – –
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
$538K +$101K +1,345 +34%
FPC
48
Falcon Point Capital
California
$351K +$58.3K +776 +29%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$346K -$15.8K -210 -6%
DCM
50
DAFNA Capital Management
California
$338K -$977K -12,996 -79%
1
2
3 4

NERV Hedge Fund Activity: Q3 2018 in Review

82 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2018, worth a combined $367M — up 54% from $238M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NERV positions and 4 closed out — a net gain of 9 holders — while 35 added to existing stakes and 16 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $11.1M. The largest seller was Fidelity Investments, cutting an estimated $16.5M.

  • 82 institutional investors held Minerva Neurosciences (NERV) as of Q3 2018, up from 73 in Q2 2018.
  • Funds reported $367M of Minerva Neurosciences stock for Q3 2018, up 54% quarter-over-quarter.
  • 13 funds opened new Minerva Neurosciences positions in Q3 2018 and 4 closed out, a net change of +9 holders.
  • The largest Minerva Neurosciences buyer in Q3 2018 was Dimensional Fund Advisors, an estimated $11.1M added.
  • The largest Minerva Neurosciences seller in Q3 2018 was Fidelity Investments, an estimated $16.5M sold.

Based on aggregated 13F filings for Q3 2018.